$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder 원문보기

소아청소년정신의학 = Journal of the Korean Academy of Child and Adolescent Psychiatry, v.31 no.1, 2020년, pp.5 - 25  

Bahn, Geon Ho (Department of Psychiatry, Kyung Hee University School of Medicine) ,  Lee, Young Sik (Department of Psychiatry, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ,  Yoo, Hanik K. (Seoul Brain Research Institute) ,  Kim, Eui-Jung (Department of Psychiatry, College of Medicine, Ewha Womans University) ,  Park, Subin (Department of Research Planning, Mental Health Research Institute, National Center for Mental Health) ,  Han, Doug Hyun (Department of Psychiatry, Chung-Ang University Hospital, Chung-Ang University College of Medicine) ,  Hong, Minha (Department of Psychiatry, Myongji Hospital, Hanyang University College of Medicine) ,  Kim, Bongseog (Department of Psychiatry, Inje University College of Medicine) ,  Lee, Soyoung Irene (Department of Psychiatry, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) ,  Bhang, Soo Young (Department of Psychiatry, Eulji University School of Medicine) ,  Lee, Seung Yup (Department of Psychiatry, Kyung Hee University School of Medicine) ,  Hong, Jin Pyo (0Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine) ,  Joung, Yoo-Sook (0Department of Psychiatry, Sams)

Abstract AI-Helper 아이콘AI-Helper

Objectives: Adult attention-deficit/hyperactivity disorder (ADHD) is an important mental health problem that needs resolution, especially considering the high rates of ADHD continuation from childhood to adolescence/adulthood and the high prevalence of ADHD in adults. Adults with ADHD have lifelong ...

주제어

참고문헌 (243)

  1. 1 Hong M Lee S Lee YS Kim B Joung YS Yoo HK Comparison of attention-deficit/hyperactivity disorder practice in adults according to a training background in child psychiatry J Korean Acad Child Adolesc Psychiatry 2019 30 121 126 10.5765/jkacap.190020 

  2. 2 Kim JH Lee EH Joung YS The WHO Adult ADHD Self-Report Scale: reliability and validity of the Korean version Psychiatry Investig 2013 10 41 46 10.4306/pi.2013.10.1.41 23482673 

  3. 3 Kim MS 9 out 10 adult ADHD patients suffer from other mental diseases such as depression: announcement of 100 psychiatrists' survey, Korean Academy Child and Adolescent Psychiatry. 2nd ADHD Day Press Meeting: results of survey on adult ADHD disease awareness and treatment 2017. Yonhap News (Seoul). 2017 Mar 28 cited 2019 July 15 Available from URL: https://www.yna.co.kr/view/AKR20170328139200017 

  4. 4 Kang T Kim J Bahn GH Song SH Kim J Kim J Development of Korean Adult ADHD Rating Scale J Korean Acad Child Adolesc Psychiatry 2015 26 295 310 10.5765/jkacap.2015.26.4.295 

  5. 5 DIVA Foundation. DIVA-5 [cited 2019 July 1] Available from URL: http://www.divacenter.eu/DIVA.aspx?id=523 

  6. 6 Lee S Choi J Kim K Kim JW Kim S Kang T The guideline of diagnosis and treatment of attention-deficit hyperactivity disorder: developed by ADHD Translational Research Center J Korean Acad Child Adolesc Psychiatry 2016 27 236 266 10.5765/jkacap.2016.27.4.236 

  7. 7 Barkley RA Attention?deficit hyperactivity disorder: a hand-book for diagnosis and treatment 3rd ed New York The Guilford Press 2006 219 247 

  8. 8 Biederman J Faraone SV Mick E Spencer T Wilens T Kiely K High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study Am J Psychiatry 1995 152 431 435 10.1176/ajp.152.3.431 7864271 

  9. 9 Biederman J Faraone S Milberger S Curtis S Chen L Marrs A Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study J Am Acad Child Adolesc Psychiatry 1996 35 343 351 10.1097/00004583-199603000-00016 8714323 

  10. 10 Biederman J Mick E Faraone SV Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type Am J Psychiatry 2000 157 816 818 10.1176/appi.ajp.157.5.816 10784477 

  11. 11 Faraone SV Biederman J Feighner JA Monuteaux MC Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol 2000 68 830 842 10.1037/0022-006X.68.5.830 11068969 

  12. 12 Faraone SV Mick E Molecular genetics of attention deficit hyperactivity disorder Psychiatr Clin North Am 2010 33 159 180 10.1016/j.psc.2009.12.004 20159345 

  13. 13 Boomsma DI Saviouk V Hottenga JJ Distel MA de Moor MH Vink JM Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults PLoS One 2010 5 e10621 10.1371/journal.pone.0010621 20485550 

  14. 14 Kan KJ Dolan CV Nivard MG Middeldorp CM van Beijsterveldt CE Willemsen G Genetic and environmental stability in attention problems across the lifespan: evidence from the Netherlands twin register J Am Acad Child Adolesc Psychiatry 2013 52 12 25 10.1016/j.jaac.2012.10.009 23265630 

  15. 15 Larsson H Asherson P Chang Z Ljung T Friedrichs B Larsson JO Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins Psychol Med 2013 43 197 207 10.1017/S0033291712001067 22894944 

  16. 16 Brikell I Kuja-Halkola R Larsson H Heritability of attentiondeficit hyperactivity disorder in adults Am J Med Genet B Neuropsychiatr Genet 2015 168 406 413 10.1002/ajmg.b.32335 26129777 

  17. 17 Zhou K Dempfle A Arcos-Burgos M Bakker SC Banaschewski T Biederman J Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 2008 147B 1392 1398 10.1002/ajmg.b.30878 18988193 

  18. 18 Zhu M Zhao S Candidate gene identification approach: progress and challenges Int J Biol Sci 2007 3 420 427 10.7150/ijbs.3.420 17998950 

  19. 19 Grevet EH Marques FZ Salgado CA Fischer AG Kalil KL Victor MM Serotonin transporter gene polymorphism and the phenotypic heterogeneity of adult ADHD J Neural Transm (Vienna) 2007 114 1631 1636 10.1007/s00702-007-0797-2 17690945 

  20. 20 Lasky-Su J Lange C Biederman J Tsuang M Doyle AE Smoller JW Family-based association analysis of a statistically derived quantitative traits for ADHD reveal an association in DRD4 with inattentive symptoms in ADHD individuals Am J Med Genet B Neuropsychiatr Genet 2008 147B 100 106 10.1002/ajmg.b.30567 17579349 

  21. 21 Lasky-Su J Neale BM Franke B Anney RJ Zhou K Maller JB Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations Am J Med Genet B Neuropsychiatr Genet 2008 147B 1345 1354 10.1002/ajmg.b.30867 18821565 

  22. 22 Lasky-Su J Anney RJ Neale BM Franke B Zhou K Maller JB Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 2008 147B 1355 1358 10.1002/ajmg.b.30869 18937294 

  23. 23 Hong JH Hwang IW Lim MH Kwon HJ Jin HJ Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children Genes Genomics 2018 40 1309 1317 10.1007/s13258-018-0726-9 30099719 

  24. 24 Kim BN Kang D Cho SC Park TW Lim MH Chung YC Shorter dinucleotide repeat length in the DRD5 gene is associated with attention deficit hyperactivity disorder Psychiatr Genet 2009 19 57 10.1097/YPG.0b013e328320803c 19125111 

  25. 25 Hawi Z Cummins TD Tong J Johnson B Lau R Samarrai W The molecular genetic architecture of attention deficit hyperactivity disorder Mol Psychiatry 2015 20 289 297 10.1038/mp.2014.183 25600112 

  26. 26 Franke B Neale BM Faraone SV Genome-wide association studies in ADHD Hum Genet 2009 126 13 50 10.1007/s00439-009-0663-4 19384554 

  27. 27 Arcos-Burgos M Jain M Acosta MT Shively S Stanescu H Wallis D A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication Mol Psychiatry 2010 15 1053 1066 10.1038/mp.2010.6 20157310 

  28. 28 Reif A Nguyen TT Weissflog L Jacob CP Romanos M Renner TJ DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders Neuropsychopharmacology 2011 36 2318 2327 10.1038/npp.2011.120 21750579 

  29. 29 Lesch KP Merker S Reif A Novak M Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD Eur Neuropsychopharmacol 2013 23 479 491 10.1016/j.euroneuro.2012.07.013 22939004 

  30. 30 Salatino-Oliveira A Genro JP Polanczyk G Zeni C Schmitz M Kieling C Cadherin-13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 2015 168B 162 169 10.1002/ajmg.b.32293 25739828 

  31. 31 Lesch KP Selch S Renner TJ Jacob C Nguyen TT Hahn T Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree Mol Psychiatry 2011 16 491 503 10.1038/mp.2010.29 20308990 

  32. 32 Ramos-Quiroga JA Nasillo V Fernandez-Aranda F Casas M Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults Expert Rev Neurother 2014 14 553 567 10.1586/14737175.2014.908708 24738746 

  33. 33 Ramos-Quiroga JA Sanchez-Mora C Casas M Garcia-Martinez I Bosch R Nogueira M Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder J Psychiatr Res 2014 49 60 67 10.1016/j.jpsychires.2013.10.022 24269040 

  34. 34 dela Pena I Kim HJ Sohn A Kim BN Han DH Ryu JH Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD) Behav Brain Funct 2014 10 17 10.1186/1744-9081-10-17 24884696 

  35. 35 Barkley RA Attention-deficit hyperactivity disorder: a hand-book for diagnosis and treatment 3rd ed New York Guilford Press 2006 704 736 

  36. 36 Bush G Valera EM Seidman LJ Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions Biol Psychiatry 2005 57 1273 1284 10.1016/j.biopsych.2005.01.034 15949999 

  37. 37 Castellanos FX Margulies DS Kelly C Uddin LQ Ghaffari M Kirsch A Cingulate-precuneus interactions: a new locus of dysfunction in adult attention-deficit/hyperactivity disorder Biol Psychiatry 2008 63 332 337 10.1016/j.biopsych.2007.06.025 17888409 

  38. 38 Ehlis AC Bahne CG Jacob CP Herrmann MJ Fallgatter AJ Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (f NIRS) study J Psychiatr Res 2008 42 1060 1067 10.1016/j.jpsychires.2007.11.011 18226818 

  39. 39 Arnsten AF Pliszka SR Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders Pharmacol Biochem Behav 2011 99 211 216 10.1016/j.pbb.2011.01.020 21295057 

  40. 40 Kesner RP Churchwell JC An analysis of rat prefrontal cortex in mediating executive function Neurobiol Learn Mem 2011 96 417 431 10.1016/j.nlm.2011.07.002 21855643 

  41. 41 Shaw P Eckstrand K Sharp W Blumenthal J Lerch JP Greenstein D Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation Proc Natl Acad Sci U S A 2007 104 19649 19654 10.1073/pnas.0707741104 18024590 

  42. 42 Hoogman M Muetzel R Guimaraes JP Shumskaya E Mennes M Zwiers MP Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples Am J Psychiatry 2019 176 531 542 10.1176/appi.ajp.2019.18091033 31014101 

  43. 43 Zametkin AJ Nordahl TE Gross M King AC Semple WE Rumsey J Cerebral glucose metabolism in adults with hyperactivity of childhood onset N Engl J Med 1990 323 1361 1366 10.1056/NEJM199011153232001 2233902 

  44. 44 Spencer TJ Biederman J Madras BK Dougherty DD Bonab AA Livni E Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane Biol Psychiatry 2007 62 1059 1061 10.1016/j.biopsych.2006.12.008 17511972 

  45. 45 Thapar A Cooper M Eyre O Langley K What have we learnt about the causes of ADHD? J Child Psychol Psychiatry 2013 54 3 16 10.1111/j.1469-7610.2012.02611.x 22963644 

  46. 46 Hong SB Im MH Kim JW Park EJ Shin MS Kim BN Environmental lead exposure and attention deficit/hyperactivity disorder symptom domains in a community sample of South Korean school-age children Environ Health Perspect 2015 123 271 276 10.1289/ehp.1307420 25280233 

  47. 47 Kim JI Kim JW Lee JM Yun HJ Sohn CH Shin MS Interaction between DRD2 and lead exposure on the cortical thickness of the frontal lobe in youth with attention-deficit/hyperactivity disorder Prog Neuropsychopharmacol Biol Psychiatry 2018 82 169 176 10.1016/j.pnpbp.2017.11.018 29169998 

  48. 48 Sadock BJ Sadock VA Ruiz P Kaplan and Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry 11th ed Philadelphia, PA Wolters Kluwer 2014 

  49. 49 American Psychiatric Association Diagnostic and statistical manual of mental disorder: DSM-IV Washington, DC American Psychiatric Press Inc 1994 

  50. 50 American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-5 Arlington, VA American Psychiatric Publishing 2013 10.1176/appi.books.9780890425596 

  51. 51 Weyandt L DuPaul G College students with ADHD: current issues and future directions New York, NY Springer 2013 10.1007/978-1-4614-5345-1 

  52. 52 Franke B Michelini G Asherson P Banaschewski T Bilbow A Buitelaar JK Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan Eur Neuropsychopharmacol 2018 28 1059 1088 10.1016/j.euroneuro.2018.08.001 30195575 

  53. 53 Adler L Cohen J Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder Psychiatr Clin North Am 2004 27 187 201 10.1016/j.psc.2003.12.003 15063992 

  54. 54 Philipp-Wiegmann F Retz-Junginger P Retz W Rosler M The intraindividual impact of ADHD on the transition of adulthood to old age Eur Arch Psychiatry Clin Neurosci 2016 266 367 371 10.1007/s00406-015-0644-7 26438010 

  55. 55 Kooij JJ Michielsen M Kruithof H Bijlenga D ADHD in old age: a review of the literature and proposal for assessment and treatment Expert Rev Neurother 2016 16 1371 1381 10.1080/14737175.2016.1204914 27334252 

  56. 56 Dalsgaard S Østergaard SD Leckman JF Mortensen PB Pedersen MG Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study Lancet 2015 385 2190 2196 10.1016/S0140-6736(14)61684-6 25726514 

  57. 57 London AS Landes SD Attention deficit hyperactivity disorder and adult mortality Prev Med 2016 90 8 10 10.1016/j.ypmed.2016.06.021 27343403 

  58. 58 Guldberg-Kjar T Johansson B Old people reporting childhood AD/HD symptoms: retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65-80 Nord J Psychiatry 2009 63 375 382 10.1080/08039480902818238 19308795 

  59. 59 Giupponi G Giordano G Maniscalco I Erbuto D Berardelli I Conca A Suicide risk in attention-deficit/hyperactivity disorder Psychiatr Danub 2018 30 2 10 10.24869/psyd.2018.2 29546852 

  60. 60 Stickley A Tachimori H Inoue Y Shinkai T Yoshimura R Nakamura J Attention-deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients Psychiatry Clin Neurosci 2018 72 713 722 10.1111/pcn.12685 29845681 

  61. 61 Polanczyk G Rohde LA Epidemiology of attention-deficit/hyperactivity disorder across the lifespan Curr Opin Psychiatry 2007 20 386 392 10.1097/YCO.0b013e3281568d7a 17551354 

  62. 62 Fayyad J Sampson NA Hwang I Adamowski T Aguilar-Gaxiola S Al-Hamzawi A The descriptive epidemiology of DSMIV Adult ADHD in the World Health Organization World Mental Health Surveys Atten Defic Hyperact Disord 2017 9 47 65 10.1007/s12402-016-0208-3 27866355 

  63. 63 Hwangbo R Chang H Hong M Cho S Bahn GH The diagnostic distribution of psychiatric disorders among the population under 19 years old: based on the National Insurance Data J Korean Acad Child Adolesc Psychiatry 2016 27 139 145 10.5765/jkacap.2016.27.2.139 

  64. 64 Moffitt TE Houts R Asherson P Belsky DW Corcoran DL Hammerle M Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study Am J Psychiatry 2015 172 967 977 10.1176/appi.ajp.2015.14101266 25998281 

  65. 65 Agnew-Blais JC Polanczyk GV Danese A Wertz J Moffitt TE Arseneault L Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood JAMA Psychiatry 2016 73 713 720 10.1001/jamapsychiatry.2016.0465 27192174 

  66. 66 Cooper M Hammerton G Collishaw S Langley K Thapar A Dalsgaard S Investigating late-onset ADHD: a population cohort investigation J Child Psychol Psychiatry 2018 59 1105 1113 10.1111/jcpp.12911 29683192 

  67. 67 Ramos-Olazagasti MA Castellanos FX Mannuzza S Klein RG Predicting the adult functional outcomes of boys with ADHD 33 years later J Am Acad Child Adolesc Psychiatry 2018 57 571 582 10.1016/j.jaac.2018.04.015 30071978 

  68. 68 Noh GM Lee SM Bahn GH Social function of adult men with attention-deficit/hyperactivity disorder in the context of military service Neuropsychiatr Dis Treat 2018 14 3349 3354 10.2147/NDT.S180806 30573958 

  69. 69 Teive HA Zavala JA Munhoz RP Lara DR Lima P Palmini A Attention deficit hyperactivity disorder and the behavior of “Che” Guevara J Clin Neurosci 2009 16 1136 1138 10.1016/j.jocn.2008.12.003 19497749 

  70. 70 Fitzgerald M Adult deficit hyperactivity disorder and other diagnosis Ir J Psychol Med 2008 25 160 10.1017/S0790966700011356 30282260 

  71. 71 Simon V Czobor P Balint S Meszaros A Bitter I Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis Br J Psychiatry 2009 194 204 211 10.1192/bjp.bp.107.048827 19252145 

  72. 72 Caye A Swanson J Thapar A Sibley M Arseneault L Hechtman L Life span studies of ADHD-conceptual challenges and predictors of persistence and outcome Curr Psychiatry Rep 2016 18 111 10.1007/s11920-016-0750-x 27783340 

  73. 73 Sibley MH Mitchell JT Becker SP Method of adult diagnosis influences estimated persistence of childhood ADHD: a systematic review of longitudinal studies Lancet Psychiatry 2016 3 1157 1165 10.1016/S2215-0366(16)30190-0 27745869 

  74. 74 Sibley MH Swanson JM Arnold LE Hechtman LT Owens EB Stehli A Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity J Child Psychol Psychiatry 2017 58 655 662 10.1111/jcpp.12620 27642116 

  75. 75 Ramos-Quiroga JA Montoya A Kutzelnigg A Deberdt W Sobanski E Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines Curr Med Res Opin 2013 29 1093 1104 10.1185/03007995.2013.812961 23742051 

  76. 76 Zalsman G Shilton T Adult ADHD: A new disease? Int J Psychiatry Clin Pract 2016 20 70 76 10.3109/13651501.2016.1149197 27052374 

  77. 77 Rigler T Manor I Kalansky A Shorer Z Noyman I Sadaka Y New DSM-5 criteria for ADHD does it matter? Compr Psychiatry 2016 68 56 59 10.1016/j.comppsych.2016.03.008 27234183 

  78. 78 Barkley RA Brown TE Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders CNS Spectr 2008 13 977 984 10.1017/S1092852900014036 19037178 

  79. 79 Matte B Anselmi L Salum GA Kieling C Goncalves H Menezes A ADHD in DSM-5: a field trial in a large, representative sample of 18to 19-year-old adults Psychol Med 2015 45 361 373 10.1017/S0033291714001470 25066615 

  80. 80 Park S Cho MJ Chang SM Jeon HJ Cho SJ Kim BS Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study Psychiatry Res 2011 186 378 383 10.1016/j.psychres.2010.07.047 20724004 

  81. 81 Kwak YS Jung YE Kim MD Prevalence and correlates of attention-deficit hyperactivity disorder symptoms in Korean college students Neuropsychiatr Dis Treat 2015 11 797 802 10.2147/NDT.S80785 25848277 

  82. 82 Faraone SV Biederman J Mick E The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies Psychol Med 2006 36 159 165 10.1017/S003329170500471X 16420712 

  83. 83 Kooij SJ Bejerot S Blackwell A Caci H Casas-Brugue M Carpentier PJ European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD BMC Psychiatry 2010 10 67 10.1186/1471-244X-10-67 20815868 

  84. 84 Pingault JB Viding E Galera C Greven CU Zheng Y Plomin R Genetic and environmental influences on the developmental course of attention-deficit/hyperactivity disorder symptoms from childhood to adolescence JAMA Psychiatry 2015 72 651 658 10.1001/jamapsychiatry.2015.0469 25945901 

  85. 85 Biederman J Attention-deficit/hyperactivity disorder: a selective overview Biol Psychiatry 2005 57 1215 1220 10.1016/j.biopsych.2004.10.020 15949990 

  86. 86 Genolini C Pingault JB Driss T Cote S Tremblay RE Vitaro F KmL3D: a non-parametric algorithm for clustering joint trajectories Comput Methods Programs Biomed 2013 109 104 111 10.1016/j.cmpb.2012.08.016 23127283 

  87. 87 Willcutt EG Nigg JT Pennington BF Solanto MV Rohde LA Tannock R Validity of DSM-IV attention deficit/hyperactivity disorder symptom dimensions and subtypes J Abnorm Psychol 2012 121 991 1010 10.1037/a0027347 22612200 

  88. 88 Willoughby MT Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations J Child Psychol Psychiatry 2003 44 88 106 10.1111/1469-7610.t01-1-00104 12553414 

  89. 89 Larsson H Dilshad R Lichtenstein P Barker ED Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology J Child Psychol Psychiatry 2011 52 954 963 10.1111/j.1469-7610.2011.02379.x 21434915 

  90. 90 Pingault JB Cote SM Vitaro F Falissard B Genolini C Tremblay RE The developmental course of childhood inattention symptoms uniquely predicts educational attainment: a 16-year longitudinal study Psychiatry Res 2014 219 707 709 10.1016/j.psychres.2014.06.022 25017615 

  91. 91 Pingault JB Tremblay RE Vitaro F Carbonneau R Genolini C Falissard B Childhood trajectories of inattention and hyperactivity and prediction of educational attainment in early adulthood: a 16-year longitudinal population-based study Am J Psychiatry 2011 168 1164 1170 10.1176/appi.ajp.2011.10121732 21799065 

  92. 92 Retz W Stieglitz RD Corbisiero S Retz-Junginger P Rosler M Emotional dysregulation in adult ADHD: What is the empirical evidence? Expert Rev Neurother 2012 12 1241 1251 10.1586/ern.12.109 23082740 

  93. 93 Surman CB Biederman J Spencer T Yorks D Miller CA Petty CR Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis Am J Psychiatry 2011 168 617 623 10.1176/appi.ajp.2010.10081172 21498464 

  94. 94 Amador-Campos JA Gomez-Benito J Ramos-Quiroga JA The conners' adult ADHD rating scales--short self-report and observer forms: psychometric properties of the Catalan version J Atten Disord 2014 18 671 679 10.1177/1087054712446831 22771453 

  95. 95 Christiansen H Kis B Hirsch O Philipsen A Henneck M Panczuk A German validation of the Conners Adult ADHD Rating Scales-self-report (CAARS-S) I: factor structure and normative data Eur Psychiatry 2011 26 100 107 10.1016/j.eurpsy.2009.12.024 20619613 

  96. 96 Kessler RC Green JG Adler LA Barkley RA Chatterji S Faraone SV Structure and diagnosis of adult attention-deficit/ hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale Arch Gen Psychiatry 2010 67 1168 1178 10.1001/archgenpsychiatry.2010.146 21041618 

  97. 97 Marchant BK Reimherr FW Robison D Robison RJ Wender PH Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale Psychol Assess 2013 25 942 950 10.1037/a0032797 23647041 

  98. 98 Sagvolden T Johansen EB Aase H Russell VA A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes Behav Brain Sci 2005 28 397 419 10.1017/S0140525X05000075 16209748 

  99. 99 Sandberg S The biopsychosocial context of ADHD Behav Brain Sci 2005 28 441 442 10.1017/S0140525X05370075 

  100. 100 Turgay A Goodman DW Asherson P Lasser RA Babcock TF Pucci ML Lifespan persistence of ADHD: the life transition model and its application J Clin Psychiatry 2012 73 192 201 10.4088/JCP.10m06628 22313720 

  101. 101 Barkley RA Fischer M Smallish L Fletcher K Young adult outcome of hyperactive children: adaptive functioning in major life activities J Am Acad Child Adolesc Psychiatry 2006 45 192 202 10.1097/01.chi.0000189134.97436.e2 16429090 

  102. 102 DuPaul GJ Weyandt LL O'Dell SM Varejao M College students with ADHD: current status and future directions J Atten Disord 2009 13 234 250 10.1177/1087054709340650 19620623 

  103. 103 Frazier TW Youngstrom EA Glutting JJ Watkins MW ADHD and achievement: meta-analysis of the child, adolescent, and adult literatures and a concomitant study with college students J Learn Disabil 2007 40 49 65 10.1177/00222194070400010401 17274547 

  104. 104 Norwalk K Norvilitis JM MacLean MG ADHD symptomatology and its relationship to factors associated with college adjustment J Atten Disord 2009 13 251 258 10.1177/1087054708320441 18669877 

  105. 105 Gray SA Fettes P Woltering S Mawjee K Tannock R Symptom manifestation and impairments in college students with ADHD J Learn Disabil 2016 49 616 630 10.1177/0022219415576523 25778457 

  106. 106 Harpin VA The effect of ADHD on the life of an individual, their family, and community from preschool to adult life Arch Dis Child 2005 90 Suppl 1 i2 7 10.1136/adc.2004.059006 15665153 

  107. 107 Gjervan B Torgersen T Nordahl HM Rasmussen K Functional impairment and occupational outcome in adults with ADHD J Atten Disord 2012 16 544 552 10.1177/1087054711413074 21725028 

  108. 108 Halmøy A Fasmer OB Gillberg C Haavik J Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients J Atten Disord 2009 13 175 187 10.1177/1087054708329777 19372500 

  109. 109 de Graaf R Kessler RC Fayyad J ten Have M Alonso J Angermeyer M The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative Occup Environ Med 2008 65 835 842 10.1136/oem.2007.038448 18505771 

  110. 110 Brook JS Brook DW Zhang C Seltzer N Finch SJ Adolescent ADHD and adult physical and mental health, work performance, and financial stress Pediatrics 2013 131 5 13 10.1542/peds.2012-1725 23230074 

  111. 111 Breslin FC Pole JD Work injury risk among young people with learning disabilities and attention-deficit/hyperactivity disorder in Canada Am J Public Health 2009 99 1423 1430 10.2105/AJPH.2008.140855 19542044 

  112. 112 Hodgkins P Montejano L Sasane R Huse D Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans: a retrospective analysis Prim Care Companion CNS Disord 2011 13 PCC.10m01031 10.4088/PCC.10m01031 21977357 

  113. 113 Kupper T Haavik J Drexler H Ramos-Quiroga JA Wermelskirchen D Prutz C The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents Int Arch Occup Environ Health 2012 85 837 847 10.1007/s00420-012-0794-0 22752312 

  114. 114 Fruchter E Marom-Harel H Fenchel D Kapra O Ginat K Portuguese S Functioning of young adults with ADHD in the military J Atten Disord 2019 23 1470 1474 10.1177/1087054716652478 27269006 

  115. 115 Lee DY Lee CS Park CS Kim BJ Cha BS Lee SJ Effect of symptoms of adult attention deficit hyperactivity disorder on symptoms of post traumatic stress disorder in Korean conscripts Psychiatry Investig 2012 9 154 160 10.4306/pi.2012.9.2.154 22707966 

  116. 116 Robin AL Payson E The impact of ADHD on marriage ADHD Rep 2002 10 9 14 10.1521/adhd.10.3.9.20553 

  117. 117 Shaw P Stringaris A Nigg J Leibenluft E Emotion dysregulation in attention deficit hyperactivity disorder Am J Psychiatry 2014 171 276 293 10.1176/appi.ajp.2013.13070966 24480998 

  118. 118 Barkley RA Murphy KR Deficient emotional self-regulation in adults with ADHD: the relative contributions of emotional impulsiveness and ADHD symptoms to adaptive impairments in major life activities J ADHD Relat Disord 2010 1 5 28 10.1521/adhd.2010.18.4.1 

  119. 119 Skirrow C Asherson P Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder J Affect Disord 2013 147 80 86 10.1016/j.jad.2012.10.011 23218897 

  120. 120 Surman CB Biederman J Spencer T Miller CA McDermott KM Faraone SV Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study Atten Defic Hyperact Disord 2013 5 273 281 10.1007/s12402-012-0100-8 23413201 

  121. 121 Morstedt B Corbisiero S Bitto H Stieglitz RD Emotional symptoms and their contribution to functional impairment in adults with attention-deficit/hyperactivity disorder Atten Defic Hyperact Disord 2016 8 21 33 10.1007/s12402-015-0181-2 26254914 

  122. 122 Minde K Eakin L Hechtman L Ochs E Bouffard R Greenfield B The psychosocial functioning of children and spouses of adults with ADHD J Child Psychol Psychiatry 2003 44 637 646 10.1111/1469-7610.00150 12751853 

  123. 123 Rhee SH Waldman ID Hay DA Levy F Sex differences in genetic and environmental influences on DSM-III-R attention-deficit/hyperactivity disorder J Abnorm Psychol 1999 108 24 41 10.1037/0021-843X.108.1.24 10066990 

  124. 124 Canu WH Carlson CL Rejection sensitivity and social outcomes of young adult men with ADHD J Atten Disord 2007 10 261 275 10.1177/1087054706288106 17242422 

  125. 125 Eakin L Minde K Hechtman L Ochs E Krane E Bouffard R The marital and family functioning of adults with ADHD and their spouses J Atten Disord 2004 8 1 10 10.1177/108705470400800101 15669597 

  126. 126 Barkley RA Cox D A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance J Safety Res 2007 38 113 128 10.1016/j.jsr.2006.09.004 17303170 

  127. 127 Rosenbloom T Wultz B Thirty-day self-reported risky driving behaviors of ADHD and non-ADHD drivers Accid Anal Prev 2011 43 128 133 10.1016/j.aap.2010.08.002 21094306 

  128. 128 Swensen A Birnbaum HG Ben Hamadi R Greenberg P Cremieux PY Secnik K Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients J Adolesc Health 2004 35 346.e1 346.e9 10.1016/j.jadohealth.2003.12.003 15830457 

  129. 129 Flory K Molina BS Pelham WE Jr Gnagy E Smith B Childhood ADHD predicts risky sexual behavior in young adulthood J Clin Child Adolesc Psychol 2006 35 571 577 10.1207/s15374424jccp3504_8 17007602 

  130. 130 Gudjonsson GH Sigurdsson JF Sigfusdottir ID Young S An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use J Child Psychol Psychiatry 2012 53 304 312 10.1111/j.1469-7610.2011.02489.x 22066497 

  131. 131 Caye A Rocha TB Anselmi L Murray J Menezes AM Barros FC Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome JAMA Psychiatry 2016 73 705 712 10.1001/jamapsychiatry.2016.0383 27192050 

  132. 132 Mannuzza S Klein RG Moulton JL 3rd Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records Psychiatry Res 2008 160 237 246 10.1016/j.psychres.2007.11.003 18707766 

  133. 133 Knecht C de Alvaro R Martinez-Raga J Balanza-Martinez V Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions Int J Adolesc Med Health 2015 27 163 175 10.1515/ijamh-2015-5007 25411986 

  134. 134 Cahill BS Coolidge FL Segal DL Klebe KJ Marle PD Overmann KA Prevalence of ADHD and its subtypes in male and female adult prison inmates Behav Sci Law 2012 30 154 166 10.1002/bsl.2004 22496046 

  135. 135 Galland D Tisserant I Notardonato L “Attention deficit hyperactivity disorder in forensic psychiatry: a review” Encephale 2017 43 268 272 10.1016/j.encep.2016.04.012 27637873 

  136. 136 Wasserstein J Diagnostic issues for adolescents and adults with ADHD J Clin Psychol 2005 61 535 547 10.1002/jclp.20118 15723419 

  137. 137 Murphy P Schachar R Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults Am J Psychiatry 2000 157 1156 1159 10.1176/appi.ajp.157.7.1156 10873926 

  138. 138 Zucker M Morris MK Ingram SM Morris RD Bakeman R Concordance of selfand informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms Psychol Assess 2002 14 379 389 10.1037/1040-3590.14.4.379 12501563 

  139. 139 Brown TE Attention-deficit disorders and comorbidities in children, adolescents, and adults Washington, NY American Psyciatric Press, Inc 2000 

  140. 140 Canela C Buadze A Dube A Eich D Liebrenz M Skills and compensation strategies in adult ADHD A qualitative study PLoS One 2017 12 e0184964 10.1371/journal.pone.0184964 28953946 

  141. 141 Adler LA Clinical presentations of adult patients with ADHD J Clin Psychiatry 2004 65 Suppl 3 8 11 15046529 

  142. 142 Mao AR Findling RL Comorbidities in adult attention-deficit/ hyperactivity disorder: a practical guide to diagnosis in primary care Postgrad Med 2014 126 42 51 10.3810/pgm.2014.09.2799 25295649 

  143. 143 Conners CK Jett JL Attention deficit hyperactivity disorder: The latest assessment and treatment strategies Kansas City, MO Compact Clinicals 1999 

  144. 144 Francks C Fisher SE Marlow AJ MacPhie IL Taylor KE Richardson AJ Familial and genetic effects on motor coordination, laterality, and reading-related cognition Am J Psychiatry 2003 160 1970 1977 10.1176/appi.ajp.160.11.1970 14594743 

  145. 145 Ronald A Simonoff E Kuntsi J Asherson P Plomin R Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample J Child Psychol Psychiatry 2008 49 535 542 10.1111/j.1469-7610.2007.01857.x 18221348 

  146. 146 Willcutt EG Pennington BF Olson RK DeFries JC Understanding comorbidity: a twin study of reading disability and attentiondeficit/hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 2007 144B 709 714 10.1002/ajmg.b.30310 17440942 

  147. 147 Kessler RC Adler L Ames M Demler O Faraone S Hiripi E The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population Psychol Med 2005 35 245 256 10.1017/S0033291704002892 15841682 

  148. 148 Heo S Kim JH Joung YS Lee WI Kim JJ Sohn SH Clinical utility of the Korean version of the WHO Adult AttentionDeficit/Hyperactivity Disorder Self-Report Scale Screener Psychiatry Investig 2018 15 325 329 10.30773/pi.2017.07.10 29486543 

  149. 149 Ustun B Adler LA Rudin C Faraone SV Spencer TJ Berglund P The World Health Organization Adult Attention-Deficit/ Hyperactivity Disorder Self-Report Screening Scale for DSM-5 JAMA Psychiatry 2017 74 520 527 10.1001/jamapsychiatry.2017.0298 28384801 

  150. 150 Conners CK Erhardt D Sparrow EP Conners' adult ADHD rating scales (CAARS): technical manual North Tonawanda, NY Multi-Health Systems Inc 1999 

  151. 151 Rossini ED O'Connor MA Retrospective self-reported symptoms of attention-deficit hyperactivity disorder: reliability of the Wender Utah Rating Scale Psychol Rep 1995 77 3 Pt 1 751 754 10.2466/pr0.1995.77.3.751 8559912 

  152. 152 Goldstein S Naglieri JA Brown Attention-Deficit-Disorder Scales for adolescents and adults Encyclopedia of child behavior and development Boston, MA Springer 2011 303 303 10.1007/978-0-387-79061-9 

  153. 153 Barkley RA Murphy KR Attention-deficit hyperactivity disorder: a clinical workbook 3rd ed New York, NY The Guilford Press 2006 

  154. 154 Young S The YAQ-S and YAQ-I: the development of self and informant questionnaires reporting on current adult ADHD symptomatology, comorbid and associated problems Pers Individ Dif 2004 36 1211 1223 10.1016/S0191-8869(03)00212-5 

  155. 155 Hong M Lee YS Kim B Joung YS Yoo HK Kim E Clinical utility and cut-off scores of the Korean Adult Attention-Deficit/Hyperactivity Disorder Rating Scale J Korean Acad Child Adolesc Psychiatry 2019 30 116 120 10.5765/jkacap.190022 

  156. 156 Barkley RA Murphy KR The nature of executive function (EF) deficits in daily life activities in adults with ADHD and their relationship to performance on EF tests J Psychopathol Behav Assess 2011 33 137 158 10.1007/s10862-011-9217-x 

  157. 157 Lee H Yang M Lee E-h Joung Y-S Hwang S-t Hong S-H Reliability and validity of the Korean version of Barkley Deficits in Executive Functioning Scale (K-BDEFS) Korean J Clin Psychol 2016 35 519 539 10.15842/kjcp.2016.35.2.010 

  158. 158 Kooij J Diagnostic instrument Adult ADHD: diagnostic assessment and treatment 3rd ed London Springer-Verlag 2013 97 98 10.1007/978-1-4471-4138-9_3 

  159. 159 Epstein JN Johnson DE Conners CK Conners' Adult ADHD Diagnostic Interview for DSM-IV™ (CAADID™) North Tonawanda, NY Multi-Health Systems Inc 2001 

  160. 160 Huh HN Kang SH Hwang SY Yoo HK Developmental trajectories of attention in normal Korean population J Korean Acad Child Adolesc Psychiatry 2019 30 66 73 10.5765/jkacap.180033 

  161. 161 Holst Y Thorell LB Neuropsychological functioning in adults with ADHD and adults with other psychiatric disorders J Atten Disord 2017 21 137 148 10.1177/1087054713506264 24134875 

  162. 162 Mostert JC Onnink AMH Klein M Dammers J Harneit A Schulten T Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: a systematic analysis of neuropsychological measurements Eur Neuropsychopharmacol 2015 25 2062 2074 10.1016/j.euroneuro.2015.08.010 26336867 

  163. 163 Skodzik T Holling H Pedersen A Long-term memory performance in adult ADHD J Atten Disord 2017 21 267 283 10.1177/1087054713510561 24232170 

  164. 164 Weyandt LL Oster DR Gudmundsdottir BG DuPaul GJ Anastopoulos AD Neuropsychological functioning in college students with and without ADHD Neuropsychology 2017 31 160 172 10.1037/neu0000326 27831696 

  165. 165 Yoo H Lee J Kang SH Park EH Jung J Kim BN Standardization of the comprehensive attention test for the Korean children and adolescents J Korean Acad Child Adolesc Psychiatry 2009 20 68 75 

  166. 166 Kooij JJ Burger H Boonstra AM Van der Linden PD Kalma LE Buitelaar JK Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial Psychol Med 2004 34 973 982 10.1017/S0033291703001776 15554568 

  167. 167 Sobanski E Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD) Eur Arch Psychiatry Clin Neurosci 2006 256 Suppl 1 i26 i31 10.1007/s00406-006-1004-4 16977548 

  168. 168 Katzman MA Bilkey TS Chokka PR Fallu A Klassen LJ Adult ADHD and comorbid disorders: clinical implications of a dimensional approach BMC Psychiatry 2017 17 302 10.1186/s12888-017-1463-3 28830387 

  169. 169 Miesch M Deister A [Attention-deficit/hyperactivity disorder (ADHD) in adult psychiatry: data on 12-month prevalence, risk factors and comorbidity] Fortschr Neurol Psychiatr 2019 87 3238 10.1055/s-0043-119987 29490380 

  170. 170 Fatseas M Hurmic H Serre F Debrabant R Daulouede JP Denis C Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions Psychiatry Res 2016 246 656 662 10.1016/j.psychres.2016.10.071 27842945 

  171. 171 Panagiotidi M Problematic video game play and ADHD traits in an adult population Cyberpsychol Behav Soc Netw 2017 20 292 295 10.1089/cyber.2016.0676 28498045 

  172. 172 Wang BQ Yao NQ Zhou X Liu J Lv ZT The association between attention deficit/hyperactivity disorder and internet addiction: a systematic review and meta-analysis BMC Psychiatry 2017 17 260 10.1186/s12888-017-1408-x 28724403 

  173. 173 Gibbins C Weiss M Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults Curr Psychiatry Rep 2007 9 420 426 10.1007/s11920-007-0055-1 17915083 

  174. 174 Kessler RC Adler L Barkley R Biederman J Conners CK Demler O The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication Am J Psychiatry 2006 163 716 723 10.1176/ajp.2006.163.4.716 16585449 

  175. 175 Klassen LJ Katzman MA Chokka P Adult ADHD and its comorbidities, with a focus on bipolar disorder J Affect Disord 2010 124 1 8 10.1016/j.jad.2009.06.036 19683348 

  176. 176 Pineiro-Dieguez B Balanza-Martinez V Garcia-Garcia P SolerLopez B CAT Study Group Psychiatric comorbidity at the time of diagnosis in adults with ADHD: The CAT Study J Atten Disord 2016 20 1066 1075 10.1177/1087054713518240 24464326 

  177. 177 Elkins RM Carpenter AL Pincus DB Comer JS Inattention symptoms and the diagnosis of comorbid attention-deficit/hyperactivity disorder among youth with generalized anxiety disorder J Anxiety Disord 2014 28 754 760 10.1016/j.janxdis.2014.09.003 25260213 

  178. 178 Reimherr FW Marchant BK Gift TE Steans TA ADHD and anxiety: clinical significance and treatment implications Curr Psychiatry Rep 2017 19 109 10.1007/s11920-017-0859-6 29152677 

  179. 179 Milberger S Biederman J Faraone SV Murphy J Tsuang MT Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms Am J Psychiatry 1995 152 1793 1799 10.1176/ajp.152.12.1793 8526248 

  180. 180 Ramsay JR Rostain AL Issues in ADHD in adults The ADHD Report 2006 14 5 8 10.1521/adhd.2006.14.6.5 

  181. 181 Ramsay JR What else could it be if it is NOT adult ADHD? cited 2019 July 15 Available from URL: https://adhdinadults.com/ what-else-could-it-be-if-it-is-not-adult-adhd/ 

  182. 182 Moukhtarian TR Mintah RS Moran P Asherson P Emotion dysregulation in attention-deficit/hyperactivity disorder and borderline personality disorder Borderline Personal Disord Emot Dysregul 2018 5 9 10.1186/s40479-018-0086-8 29796281 

  183. 183 Asherson P Young AH Eich-Hochli D Moran P Porsdal V Deberdt W Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults Curr Med Res Opin 2014 30 1657 1672 10.1185/03007995.2014.915800 24804976 

  184. 184 Matthies SD Philipsen A Common ground in Attention Deficit Hyperactivity Disorder (ADHD) and Borderline Personality Disorder (BPD)-review of recent findings Borderline Personal Disord Emot Dysregul 2014 1 3 10.1186/2051-6673-1-3 26843958 

  185. 185 Witt O Brucher K Biegel G Petermann F Schmidt S [Adult ADHD versus borderline personality disorder: criteria for differential diagnosis] Fortschr Neurol Psychiatr 2014 82 337 345 10.1055/s-0034-1366242 24901317 

  186. 186 D'Amelio R Retz W Philipsen A Rosler M Psychoedukation und Coaching ADHS im Erwachsenenalter: Manual zur Leitung von Patientenund Angehorigengruppen Munich Urban & Fischer 2008 

  187. 187 National Collaborating Centre for Mental Health Attention deficit hyperactivity disorder: diagnosis and management of ADHD in children, young people and adults (NICE Clinical Guidelines, No. 72) Leicester THe British Psychological Society & The Royal College of Psychiatrists 2009 

  188. 188 Bolea-Alamanac B Nutt DJ Adamou M Asherson P Bazire S Coghill D Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology J Psychopharmacol 2014 28 179 203 10.1177/0269881113519509 24526134 

  189. 189 Volkow ND Swanson JM Clinical practice: adult attention deficit-hyperactivity disorder N Engl J Med 2013 369 1935 1944 10.1056/NEJMcp1212625 24224626 

  190. 190 Kooij JJS Bijlenga D Salerno L Jaeschke R Bitter I Balazs J Updated European Consensus Statement on diagnosis and treatment of adult ADHD Eur Psychiatry 2019 56 14 34 10.1016/j.eurpsy.2018.11.001 30453134 

  191. 191 Faraone SV Glatt SJ A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes J Clin Psychiatry 2010 71 754 763 10.4088/JCP.08m04902pur 20051220 

  192. 192 Banaschewski T Coghill D Santosh P Zuddas A Asherson P Buitelaar J Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline Eur Child Adolesc Psychiatry 2006 15 476 495 10.1007/s00787-006-0549-0 16680409 

  193. 193 Philipsen A Jans T Graf E Matthies S Borel P Colla M Effects of group psychotherapy, individual counseling, methylphenidate, and placebo in the treatment of adult attention-deficit/ hyperactivity disorder: a randomized clinical trial JAMA Psychiatry 2015 72 1199 1210 10.1001/jamapsychiatry.2015.2146 26536057 

  194. 194 Chang Z D'Onofrio BM Quinn PD Lichtenstein P Larsson H Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study Biol Psychiatry 2016 80 916 922 10.1016/j.biopsych.2016.02.018 27086545 

  195. 195 Chen Q Sjolander A Runeson B D'Onofrio BM Lichtenstein P Larsson H Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study BMJ 2014 348 g3769 10.1136/bmj.g3769 24942388 

  196. 196 Chang Z Lichtenstein P Halldner L D'Onofrio B Serlachius E Fazel S Stimulant ADHD medication and risk for substance abuse J Child Psychol Psychiatry 2014 55 878 885 10.1111/jcpp.12164 25158998 

  197. 197 Chang Z Lichtenstein P D'Onofrio BM Sjolander A Larsson H Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a populationbased study JAMA Psychiatry 2014 71 319 325 10.1001/jamapsychiatry.2013.4174 24477798 

  198. 198 Lichtenstein P Larsson H Medication for attention deficit-hyperactivity disorder and criminality N Engl J Med 2013 368 776 10.1056/NEJMc1215531 23425178 

  199. 199 Sharman J Pennick M Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells Neuropsychiatr Dis Treat 2014 10 2275 2280 10.2147/NDT.S70382 25489246 

  200. 200 Setyawan J Hodgkins P Guerin A Gauthier G Cloutier M Wu EQ Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis J Med Econ 2013 16 962 975 10.3111/13696998.2013.800524 23621503 

  201. 201 Adler LA Goodman DW Kollins SH Weisler RH Krishnan S Zhang Y Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder J Clin Psychiatry 2008 69 1364 1373 10.4088/JCP.v69n0903 19012818 

  202. 202 Wigal T Brams M Gasior M Gao J Squires L Giblin J 316 Study Group Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design Behav Brain Funct 2010 6 34 10.1186/1744-9081-6-34 20576091 

  203. 203 Dupaul GJ Weyandt LL Rossi JS Vilardo BA O'Dell SM Carson KM Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD J Atten Disord 2012 16 202 220 10.1177/1087054711427299 22166471 

  204. 204 Maneeton N Maneeton B Suttajit S Reungyos J Srisurapanont M Martin SD Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD Drug Des Devel Ther 2014 8 1685 1693 10.2147/DDDT.S68393 25336914 

  205. 205 Coghill DR Caballero B Sorooshian S Civil R A systematic review of the safety of lisdexamfetamine dimesylate CNS Drugs 2014 28 497 511 10.1007/s40263-014-0166-2 24788672 

  206. 206 Adler LA Dirks B Deas PF Raychaudhuri A Dauphin MR Lasser RA Lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder who report clinically significant impairment in executive function: results from a randomized, double-blind, placebo-controlled study J Clin Psychiatry 2013 74 694 702 10.4088/JCP.12m08144 23945447 

  207. 207 Castells X Ramos-Quiroga JA Rigau D Bosch R Nogueira M Vidal X Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis CNS Drugs 2011 25 157 169 10.2165/11539440-000000000-00000 21254791 

  208. 208 Epstein T Patsopoulos NA Weiser M Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults Cochrane Database Syst Rev 2014 9 CD005041 10.1002/14651858.CD005041.pub2 25230710 

  209. 209 Martinez-Raga J Knecht C Szerman N Martinez MI Risk of serious cardiovascular problems with medications for attentiondeficit hyperactivity disorder CNS Drugs 2013 27 15 30 10.1007/s40263-012-0019-9 23160939 

  210. 210 Coghill D Banaschewski T Zuddas A Pelaz A Gagliano A Doepfner M Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies BMC Psychiatry 2013 13 237 10.1186/1471-244X-13-237 24074240 

  211. 211 Mick E McManus DD Goldberg RJ Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults Eur Neuropsychopharmacol 2013 23 534 541 10.1016/j.euroneuro.2012.06.011 22796229 

  212. 212 Westover AN Halm EA Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review BMC Cardiovasc Disord 2012 12 41 10.1186/1471-2261-12-41 22682429 

  213. 213 Habel LA Cooper WO Sox CM Chan KA Fireman BH Arbogast PG ADHD medications and risk of serious cardiovascular events in young and middle-aged adults JAMA 2011 306 2673 2683 10.1001/jama.2011.1830 22161946 

  214. 214 Schelleman H Bilker WB Kimmel SE Daniel GW Newcomb C Guevara JP Methylphenidate and risk of serious cardiovascular events in adults Am J Psychiatry 2012 169 178 185 10.1176/appi.ajp.2011.11010125 22318795 

  215. 215 Shin JY Roughead EE Park BJ Pratt NL Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study BMJ 2016 353 i2550 10.1136/bmj.i2550 27245699 

  216. 216 Cunill R Castells X Tobias A Capella D Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression Pharmacoepidemiol Drug Saf 2013 22 961 969 10.1002/pds.3473 23813665 

  217. 217 Adler LA Liebowitz M Kronenberger W Qiao M Rubin R Hollandbeck M Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder Depress Anxiety 2009 26 212 221 10.1002/da.20549 19194995 

  218. 218 Atomoxetine ADHD and Comorbid MDD Study Group Bangs ME Emslie GJ Spencer TJ Ramsey JL Carlson C Bartky EJ Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression J Child Adolesc Psychopharmacol 2007 17 407 420 10.1089/cap.2007.0066 17822337 

  219. 219 Medori R Ramos-Quiroga JA Casas M Kooij JJ Niemela A Trott GE A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder Biol Psychiatry 2008 63 981 989 10.1016/j.biopsych.2007.11.008 18206857 

  220. 220 Vaughan B Fegert J Kratochvil CJ Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder Expert Opin Pharmacother 2009 10 669 676 10.1517/14656560902762873 19239401 

  221. 221 Maneeton N Maneeton B Intaprasert S Woottiluk P A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder Neuropsychiatr Dis Treat 2014 10 1439 1449 10.2147/NDT.S62714 25120365 

  222. 222 Hamedi M Mohammdi M Ghaleiha A Keshavarzi Z Jafarnia M Keramatfar R Bupropion in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind study Acta Med Iran 2014 52 675 680 25325205 

  223. 223 Posey DJ McDougle CJ Guanfacine and guanfacine extended release: treatment for ADHD and related disorders CNS Drug Rev 2007 13 465 474 10.1111/j.1527-3458.2007.00026.x 18078429 

  224. 224 Huss M Chen W Ludolph AG Guanfacine extended release: a new pharmacological treatment option in Europe Clin Drug Investig 2016 36 1 25 10.1007/s40261-015-0336-0 26585576 

  225. 225 Butterfield ME Saal J Young B Young JL Supplementary guanfacine hydrochloride as a treatment of attention deficit hyperactivity disorder in adults: a double blind, placebo-controlled study Psychiatry Res 2016 236 136 141 10.1016/j.psychres.2015.12.017 26730446 

  226. 226 Kollins SH Jain R Brams M Segal S Findling RL Wigal SB Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD Pediatrics 2011 127 e1406 e1413 10.1542/peds.2010-1260 21555501 

  227. 227 Jain R Segal S Kollins SH Khayrallah M Clonidine extendedrelease tablets for pediatric patients with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 2011 50 171 179 10.1016/j.jaac.2010.11.005 21241954 

  228. 228 Palumbo DR Sallee FR Pelham WE Jr Bukstein OG Daviss WB McDERMOTT MP; CAT STUDY TEAM Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes J Am Acad Child Adolesc Psychiatry 2008 47 180 188 10.1097/chi.0b013e31815d9af7 18182963 

  229. 229 Hazell PL Stuart JE A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children J Am Acad Child Adolesc Psychiatry 2003 42 886 894 10.1097/01.CHI.0000046908.27264.00 12874489 

  230. 230 Otasowie J Castells X Ehimare UP Smith CH Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents Cochrane Database Syst Rev 2014 9 CD006997 10.1002/14651858.CD006997.pub2 25238582 

  231. 231 Prince JB Wilens TE Biederman J Spencer TJ Millstein R Polisner DA A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder J Child Adolesc Psychopharmacol 2000 10 193 204 10.1089/10445460050167304 11052409 

  232. 232 Weiss M Hechtman L Adult ADHD Research Group A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults J Clin Psychiatry 2006 67 611 619 10.4088/JCP.v67n0412 16669726 

  233. 233 Arnold VK Feifel D Earl CQ Yang R Adler LA A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dosefinding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD J Atten Disord 2014 18 133 144 10.1177/1087054712441969 22617860 

  234. 234 Riahi F Tehrani-Doost M Shahrivar Z Alaghband-Rad J Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial Hum Psychopharmacol 2010 25 570 576 10.1002/hup.1158 21312292 

  235. 235 Ghanizadeh A A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder Nord J Psychiatry 2015 69 241 248 10.3109/08039488.2014.972975 25415763 

  236. 236 Seixas M Weiss M Muller U Systematic review of national and international guidelines on attention-deficit hyperactivity disorder J Psychopharmacol 2012 26 753 765 10.1177/0269881111412095 21948938 

  237. 237 Arnold LE Hodgkins P Caci H Kahle J Young S Effect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic review PLoS One 2015 10 e0116407 10.1371/journal.pone.0116407 25714373 

  238. 238 Philipsen A Psychotherapy in adult attention deficit hyperactivity disorder: implications for treatment and research Expert Rev Neurother 2012 12 1217 1225 10.1586/ern.12.91 23082738 

  239. 239 Mongia M Hechtman L Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials Curr Psychiatry Rep 2012 14 561 567 10.1007/s11920-012-0303-x 22878974 

  240. 240 Hirvikoski T Waaler E Alfredsson J Pihlgren C Holmstrom A Johnson A Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial Behav Res Ther 2011 49 175 185 10.1016/j.brat.2011.01.001 21295767 

  241. 241 Young S Emilsson B Sigurdsson JF Khondoker M PhilippWiegmann F Baldursson G A randomized controlled trial reporting functional outcomes of cognitive-behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology Eur Arch Psychiatry Clin Neurosci 2017 267 267 276 10.1007/s00406-016-0735-0 27752827 

  242. 242 Jensen CM Amdisen BL Jørgensen KJ Arnfred SM Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses Atten Defic Hyperact Disord 2016 8 3 11 10.1007/s12402-016-0188-3 26801998 

  243. 243 Weiss M Safren SA Solanto MV Hechtman L Rostain AL Ramsay JR Research forum on psychological treatment of adults with ADHD J Atten Disord 2008 11 642 651 10.1177/1087054708315063 18417729 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로